Ultradin 75 mg/5 ml (Syrup)
100 ml bottle: ৳ 50.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Ranitidine hydrochloride |
| Company | Globe pharmaceuticals ltd |
| Also available as |
Title
- Ultradin Ranitidine Tablet & Syrup
Categories
- Medicine
- Gastrointestinal Drugs
- H2-Receptor Antagonist
Description
- Ranitidine competitively blocks histamine at H2-receptors of the gastric parietal cells which inhibits gastric acid secretion.
- Ranitidine is indicated in the treatment of active duodenal ulcer, benign gastric ulcer, treatment & prevention of ulcer associated with non-steroidal anti-inflammatory agent, postoperative stress ulcer, Zollinger-Ellison Syndrome, gastroesophageal reflux disease (GERD)
Color Options
- White
Dosage & Administration
- 150 mg twice daily taken in the morning and evening or 300 mg as a single daily dose at night for 4 to 8 weeks for duodenal and gastric ulcer
- 150 mg twice daily or 300 mg at bedtime for up to 8 weeks for reflux esophagitis
- 150 mg 3 times daily and increased if necessary up to 6 g daily in divided doses for Zollinger Ellison syndrome
- 150 mg twice daily or 300 mg at bedtime for up to 6 weeks for episodic dyspepsia
- 150 mg at night for preventing recurrences for maintenance
- 2-4 mg/kg twice daily, maximum 300 mg daily for children with peptic ulcer
- Ranitidine injection may be given in a variety of methods for different indications
Interaction
- Delayed absorption and increased peak serum concentration with propantheline bromide
- Minimally inhibits hepatic metabolism of coumarin anticoagulants, theophylline, diazepam and propranolol
- May alter absorption of pH-dependent drugs (e.g. ketoconazole, midazolam, glipizide)
- May reduce bioavailability with antacids
Contraindications
- Patients hypersensitive to Ranitidine
Side Effects
- Altered bowel habit
- Dizziness
- Rash
- Tiredness
- Reversible confusional states
- Headache
- Decreased blood counts
- Muscle or joint pain
Pregnancy & Lactation
- Ranitidine crosses the placenta
- Ranitidine is excreted in human breast milk
Precautions & Warnings
- Ultradin should be given in reduced dosage to patients with impaired renal and hepatic function
Use in Special Populations
- Ulcer healing rates have been found similar in elderly patients
- No difference in the incidence of adverse effects in elderly patients
Overdose Effects
- Specific action with no particular problems expected following overdosage
- Symptomatic and supportive therapy should be given as appropriate
- If required, the drug may be removed from the plasma by hemodialysis
Therapeutic Class
- H2 receptor antagonist
Reconstitution
- Ultradin 50 mg diluted to a concentration ≤2.5 mg/mL with appropriate solutions for IV administration
Storage Conditions
- Store in a cool and dry place
- Protect from light